Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/233.5
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Polycyclo ring system having the additional hetero ring as one of the cyclos > Bicyclo ring system having the additional hetero ring as one of the cyclos
Description: Subject matter in which the additional hetero ring is one of the cyclos of a bicyclo ring system.










Sub-classes under this class:

Class Number Class Name Patents
514/233.8 Plural ring hetero atoms in the bicyclo ring system 445
514/235.2 Ring nitrogen in the bicyclo ring system 665


Patents under this class:
1 2 3 4 5 6 7 8 9

Patent Number Title Of Patent Date Issued
6610687 Benzofuranylsulfonates Aug. 26, 2003
6610677 Pyrazole compounds useful as protein kinase inhibitors Aug. 26, 2003
6608057 Compounds useful as reversible inhibitors of cathepsin S Aug. 19, 2003
6608089 Derivatives of flavones, xanthones and coumarins Aug. 19, 2003
6596745 Method for treating fibrotic diseases with azolium chroman compounds Jul. 22, 2003
6593324 Dervatives of quinoline as alpha-2 antagonists Jul. 15, 2003
6579885 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof Jun. 17, 2003
6566389 Therapeutic uses of melatonin May. 20, 2003
6555518 Gemcitabine as an immunosuppressive pharmaceutical agent Apr. 29, 2003
6552054 Chromone derivatives, process for the preparation of the same and uses thereof Apr. 22, 2003
6514970 Urotensin-II receptor antagonists Feb. 4, 2003
6514967 Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same Feb. 4, 2003
6492393 Compounds useful as anti-inflammatory agents Dec. 10, 2002
6479486 Azabicyclic spiroether derivatives and their use as therapeutic agents Nov. 12, 2002
6448247 Method for treating an inflammatory disease Sep. 10, 2002
6440958 Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods Aug. 27, 2002
6436980 Peptidomimetic efflux pump inhibitors Aug. 20, 2002
6420427 Aminobutyric acid derivatives Jul. 16, 2002
6413956 Substituted 4-oxo-quinoline-3-carboxamides Jul. 2, 2002
6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists Jun. 25, 2002
6391901 Thrombin inhibitors May. 21, 2002
6391874 Fused heterocyclic compounds as protein tyrosine kinase inhibitors May. 21, 2002
6380211 Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity Apr. 30, 2002
6372739 Compounds and methods for modulation of estrogen receptors Apr. 16, 2002
6362179 Salts of an optically-active sulfoxide derivative Mar. 26, 2002
6358978 Substituted benzimidazoles Mar. 19, 2002
6355672 Benzothiepin derivatives, process for the preparation of the same and uses thereof Mar. 12, 2002
6333323 Indole derivatives with antiviral activity Dec. 25, 2001
6326385 Methods for treating or preventing pain Dec. 4, 2001
6294534 Spiropiperidine derivatives as melanocortin receptor agonists Sep. 25, 2001
6291456 Compounds and methods for modulation of estrogen receptors Sep. 18, 2001
6288059 Acylated hetero-alicyclic derivatives Sep. 11, 2001
6288105 Antithrombotic agents Sep. 11, 2001
6284756 Antithrombotic agents Sep. 4, 2001
6277877 Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors Aug. 21, 2001
6271227 Antithrombotic Agents Aug. 7, 2001
6251921 Antithrombotic diamines Jun. 26, 2001
6224872 Composition May. 1, 2001
6197790 Benzothiophene compounds, intermediates, compositions, and methods Mar. 6, 2001
6197785 Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity Mar. 6, 2001
6194413 Hemoregulatory compounds Feb. 27, 2001
6194450 Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof Feb. 27, 2001
6184221 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them Feb. 6, 2001
6159967 Heterocyclic compounds having tachykinin receptor antagonist activity their preparation and their use Dec. 12, 2000
6156787 Substituted thienlycyclohexanone derivatives for enhancing cognition Dec. 5, 2000
6150356 Potassium channel inhibitors and method Nov. 21, 2000
6127398 Substituted indazole derivatives and related compounds Oct. 3, 2000
6124284 Bicyclic amide derivatives and their use as muscle relaxants Sep. 26, 2000
6121261 Method for treating attention deficit disorder Sep. 19, 2000
6121292 Methods for reversing multidrug resistance Sep. 19, 2000

1 2 3 4 5 6 7 8 9










 
 
  Recently Added Patents
Viruses lacking epithelial cell receptor entry
Semiconductor device and method of manufacturing the same
High throughput thin film characterization and defect detection
Rose plant named `ESM R057`
Imaging apparatus for calculating a histogram to adjust color balance
Determination of copy number variations using binomial probability calculations
Test method for inspection device, particularly for label seating inspection device
  Randomly Featured Patents
Interval-timing facility using overbuilt hierarchical timing wheels
Microcomputer-controlled television/telephone system and method therefore
Radio with flashlight
Method for determining 3-axis spacecraft attitude
Method, system and program product for transforming a single language program into multiple language programs
Epitaxial process for III-V compound semiconductor
Bed
Apparatus for the identification of free-lying cells
Lubricating structure for a four-stroke engine
Method and system to communicate prioritized traffic via fixed length data communication frames